Marissa  J. Defreitas

Dr. Marissa J. Defreitas


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2022 in JAMA Network Open
Verified
Journal Article
Open access
PDF file
MSMichelle C. Starr
Michelle C. Starr
RGRussell Griffin
Russell Griffin
KGKatja M. Gist
Katja M. Gist
JSJeffrey L. Segar
Jeffrey L. Segar
RRRupesh Raina
Rupesh Raina
MZMichael Zappitelli
Michael Zappitelli
Importance: Extremely low gestational age neonates are at risk of disorders of fluid balance (FB), defined as change in fluid weight over a specific period. Few data exist on the association between FB and respiratory outcomes in this population.Objective: To describe FB patterns and evaluate the association of FB with respiratory outcomes in a cohort of extremely low gestational age neonates.Design, Setting, and Participants: This study is a secondary analysis of the Preterm Erythropoietin Neuroprotection Trial (PENUT), a phase 3 placebo-controlled randomized clinical trial of erythropoietin in extremely premature neonates conducted in 30 neonatal intensive care units in the US from December 1, 2013, to September 31, 2016. This analysis included 874 extremely premature neonates born at 24 to 27 weeks’ gestation who were enrolled in the PENUT study. Secondary analysis was performed in November 2021.Exposures: Primary exposure was peak FB during the first 14 postnatal days. The FB was calculated as percent change in weight from birth weight (BW) as a surrogate for FB.Main Outcomes and Measures: The primary outcome was mechanical ventilation on postnatal day 14. The secondary outcome was a composite of severe bronchopulmonary dysplasia (BPD) or death.Results: A total of 874 neonates (449 [51.4%] male; mean [SD] BW, 801 [188] g; 187 [21.4%] Hispanic, 676 [77.3%] non-Hispanic, and 11 [1.3%] of unknown ethnicity; 226 [25.9%] Black, 569 [65.1%] White, 51 [5.8%] of other race, and 28 [3.2%] of unknown race) were included in this analysis. Of these 874 neonates, 458 (52.4%) received mechanical ventilation on postnatal day 14, and 291 (33.3%) had severe BPD or had died. Median peak positive FB was 11% (IQR, 4%-20%), occurring on postnatal day 13 (IQR, 9-14). A total of 93 (10.6%) never decreased below their BW. Neonates requiring mechanical ventilation at postnatal day 14 had a higher peak FB compared with those who did not require mechanical ventilation (15% above BW vs 8% above BW, P < .001). On postnatal day 3, neonates requiring mechanical ventilation were more likely to have a higher FB (5% below BW vs 8% below BW, P < .001). The median time to return to BW was shorter in neonates who received mechanical ventilation (7 vs 8 days, P < .001) and those with severe BPD (7 vs 8 days, P < .001). After adjusting for confounding variables, for every 10% increase in peak FB during the first 14 postnatal days, there was 103% increased odds of receiving mechanical ventilation at postnatal day 14 (adjusted odds ratio, 2.03; 95% CI, 1.64-2.51).Conclusions and Relevance: In this secondary analysis of a randomized clinical trial, peak FB was associated with mechanical ventilation on postnatal day 14 and severe BPD or death. Fluid balance in the first 3 postnatal days and time to return to BW may be potential targets to help guide management and improve respiratory outcomes.Trial Registration: ClinicalTrials.gov Identifier: NCT01378273

9 February 2016 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
MDMarissa J. Defreitas
Marissa J. Defreitas
WSWacharee Seeherunvong
Wacharee Seeherunvong
CKChryso P. Katsoufis
Chryso P. Katsoufis
SRSatish RamachandraRao
Satish RamachandraRao
SDShahnaz Duara
Shahnaz Duara
CACarolyn L. Abitbol
Carolyn L. Abitbol

14 February 2020 in Pediatric Research
Verified
Journal Article
Closed access
PDF file
MAMohammed Farhan Ali
Mohammed Farhan Ali
SVSunil Kumar Bathally Venkatarayappa
Sunil Kumar Bathally Venkatarayappa
MBMerline Benny
Merline Benny
CRClaudia Rojas
Claudia Rojas
KYKeyvan Yousefi
Keyvan Yousefi
KYKaren C. Young
Karen C. Young

30 June 2022 in Frontiers in Pediatrics
Verified
Journal Article
Open access
MDMarissa J. Defreitas
Marissa J. Defreitas
CKChryso P. Katsoufis
Chryso P. Katsoufis
MBMerline Benny
Merline Benny
KYKaren Young
Karen Young
SKShathiyah Kulandavelu
Shathiyah Kulandavelu
CACarolyn L. Abitbol
Carolyn L. Abitbol
Oxidative stress occurs when there is an imbalance between reactive oxygen species/reactive nitrogen species and antioxidant systems. The interplay between these complex processes is crucial for normal pregnancy and fetal development; however, when oxidative stress predominates, pregnancy related complications and adverse fetal programming such as preterm birth ensues. Understanding how oxidative stress negatively impacts outcomes for the maternal-fetal dyad has allowed for the exploration of antioxidant therapies to prevent and/or mitigate disease progression. In the developing kidney, the negative impact of oxidative stress has also been noted as it relates to the development of hypertension and kidney injury mostly in animal models. Clinical research addressing the implications of oxidative stress in the developing kidney is less developed than that of the neurodevelopmental and respiratory conditions of preterm infants and other vulnerable neonatal groups. Efforts to study the oxidative stress pathway along the continuum of the perinatal period using a team science approach can help to understand the multi-organ dysfunction that the maternal-fetal dyad sustains and guide the investigation of antioxidant therapies to ameliorate the global toxicity. This educational review will provide a comprehensive and multidisciplinary perspective on the impact of oxidative stress during the perinatal period in the development of maternal and fetal/neonatal complications, and implications on developmental programming of accelerated aging and cardiovascular and renal disease for a lifetime.

17 January 2020 in Pediatric Nephrology
Verified
Journal Article
Closed access
PDF file
MDMarissa J. Defreitas
Marissa J. Defreitas
CKChryso P. Katsoufis
Chryso P. Katsoufis
JIJuan C. Infante
Juan C. Infante
MGMichael L. Granda
Michael L. Granda
CACarolyn L. Abitbol
Carolyn L. Abitbol
AFAlessia Fornoni
Alessia Fornoni

13 March 2024 in Kidney360
Verified
Journal Article
Open access
SSSidharth Kumar Sethi
Sidharth Kumar Sethi
JMJohn Mahan
John Mahan
JHJieji Hu
Jieji Hu
Abhilash KoratalaAbhilash Koratala
Abhilash Koratala
KSKritika Soni
Kritika Soni
RRRupesh Raina
Rupesh Raina
Key Points: Despite a high need and interest in point-of-care ultrasound (POCUS) in trainees and faculty of Pediatric Nephrology, the majority are not receiving POCUS training. There is a need to establish a structured pediatric nephrology POCUS program for clinicians and fellows. This study suggests a blueprint of POCUS curriculum which can serve as a foundation for POCUS education in pediatric nephrology centers worldwide. Background: Point-of-care ultrasound (POCUS) is commonly used in adult specialties, pediatric emergency medicine, and neonatal and pediatric critical care. Specifically, in the field of pediatric nephrology, POCUS plays a valuable role in the critical inpatient and outpatient settings. However, the lack of guidelines and a standardized curriculum for POCUS in pediatric nephrology has led to substantial discrepancies in both clinical practice and training. Methods: A multinational, multicenter survey regarding POCUS usefulness and training was sent to 225 pediatric nephrology residents, fellows, and physicians with expertise in pediatric nephrology. On the basis of the results, an ideal pediatric nephrology POCUS curriculum was formulated with a panel of experts from across the world. Eighteen experts were included, with each expert having >10 years of experience in using POCUS in adult and pediatric nephrology. A Delphi method was used to further solidify guidelines regarding the content, curriculum, and vital skills of using POCUS in pediatric nephrology. Results: A total of 134 pediatric nephrology trainees, specialists, and faculty responded to the survey (59.6% completion rate). A total of 87.4% of respondents believe that formal POCUS training is either highly desirable or should be mandatory in pediatric nephrology fellowship programs. Identified barriers to receiving training included lack of an organized curriculum, lack of POCUS experts and pediatric intensivists, lack of ultrasound equipment, lack of financial support, and lack of dedicated time during training. An expert panel was convened, and a Delphi survey was conducted to formulate guidelines to overcome the barriers to pediatric nephrology POCUS and standardize the training process. Conclusions: After collaborating with prominent pediatric nephrologists, global POCUS experts proposed a comprehensive POCUS training curriculum tailored specifically for pediatric nephrology trainees, with an appeal for all pediatric nephrology education programs to integrate POCUS instruction into their curricula.